HeartSciences (HSCS) Other Non-Current Liabilities (2022 - 2024)
HeartSciences (HSCS) posted quarterly Other Non-Current Liabilities of $32103.0 for Q4 2024, down 84.54% on a QoQ basis from $207592.0 in Q3 2023.
HeartSciences (HSCS) Other Non-Current Liabilities (2022 - 2024) Analysis & Trends
HeartSciences (HSCS) has reported Other Non-Current Liabilities for 3 consecutive years, with $32103.0 the latest figure, recorded in Q4 2024.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $32103.0 in Q4 2024, while the trailing twelve-month figure through Oct 2024 was $32103.0 (changed N/A YoY) and the FY2023 annual result came in at $187450.0, down 19.5% from the prior year.
- Other Non-Current Liabilities eased to $32103.0 in Q4 2024 per HSCS's latest filing, from $207592.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for HSCS reached as high as $232868.0 in Q2 2022 and fell as low as $32103.0 in Q4 2024.
- A 3-year average of $166926.3 and a median of $195514.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- The largest YoY upside for Other Non-Current Liabilities was 50.46% in 2023 against a maximum downside of 19.5% in 2023.
- Year by year, Other Non-Current Liabilities stood at $137967.0 in 2022, then soared by 50.46% to $207592.0 in 2023, then sank by 84.54% to $32103.0 in 2024.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $32103.0, $207592.0, and $187450.0 for Q4 2024, Q3 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2024 | 32,103.00 |
| Jul 31, 2023 | 207,592.00 |
| Apr 30, 2023 | 187,450.00 |
| Jan 31, 2023 | 203,578.00 |
| Jul 31, 2022 | 137,967.00 |
| Apr 30, 2022 | 232,868.00 |